Literature DB >> 9174981

Improved high-performance liquid chromatographic procedure for the separation and quantification of hydroxytestosterone metabolites.

M P Purdon1, L D Lehman-McKeeman.   

Abstract

A reproducible, sensitive high-performance liquid chromatography (HPLC) method has been developed to quantify hydroxytestosterone metabolites. The method features a simple one-step linear gradient of methanol in water (10%-60% methanol) for separation of the testosterone metabolites on a Supelcosil LC-18 column; metabolites are detected at 247 nm. This method provides a distinct advantage over previously developed assays in that the solvent gradient does not contribute to baseline changes throughout the chromatographic run. In this way, the flat baseline markedly improves robustness of the assay and simplifies peak integration and quantification. At the same time, resolution of 15 different steroid metabolites catalyzed by the cytochrome P-450 enzymes are readily separated in rat or mouse liver microsomes. An internal standard, cortexolone, was selected for use based on its structural and spectral similarity to the hydroxytestosterone metabolites, and quantification is based on the molar response for the testosterone/cortexolone peak area ratio. The limit of detection (LOD) is 1 pmol on-column with a limit of quantitation (LOQ) of 4 pmol on-column. The intraday repeatability is approximately 3%. This simplified procedure is straightforward and should greatly facilitate the routine use of the testosterone hydroxylation assay to measure cytochrome P-450 isozyme activity.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9174981     DOI: 10.1016/s1056-8719(97)00013-0

Source DB:  PubMed          Journal:  J Pharmacol Toxicol Methods        ISSN: 1056-8719            Impact factor:   1.950


  8 in total

1.  Effect of Benincasa hispida fruits on testosterone-induced prostatic hypertrophy in albino rats.

Authors:  Chetan Nandecha; Alok Nahata; Vinod Kumar Dixit
Journal:  Curr Ther Res Clin Exp       Date:  2010-10

2.  Significantly reduced cytochrome P450 3A4 expression and activity in liver from humans with diabetes mellitus.

Authors:  Miroslav Dostalek; Michael H Court; Bingfang Yan; Fatemeh Akhlaghi
Journal:  Br J Pharmacol       Date:  2011-07       Impact factor: 8.739

3.  Microsomal cytochrome P450 levels and activities of isolated rat livers perfused with albumin.

Authors:  Ragini Vuppugalla; Rakhi B Shah; Anjaneya P Chimalakonda; Charles W Fisher; Reza Mehvar
Journal:  Pharm Res       Date:  2003-01       Impact factor: 4.200

4.  Chlordecone, a mixed pregnane X receptor (PXR) and estrogen receptor alpha (ERalpha) agonist, alters cholesterol homeostasis and lipoprotein metabolism in C57BL/6 mice.

Authors:  Junga Lee; Richard C Scheri; Yuan Zhang; Lawrence R Curtis
Journal:  Toxicol Appl Pharmacol       Date:  2008-08-26       Impact factor: 4.219

5.  Comparison of CYP3A4 and CYP3A5: the effects of cytochrome b5 and NADPH-cytochrome P450 reductase on testosterone hydroxylation activities.

Authors:  Su-Jun Lee; Joyce A Goldstein
Journal:  Drug Metab Pharmacokinet       Date:  2012-06-12       Impact factor: 3.614

6.  Evaluation of hair growth promoting activity of Phyllanthus niruri.

Authors:  Satish Patel; Vikas Sharma; Nagendra S Chauhan; Mayank Thakur; Vinod Kumar Dixit
Journal:  Avicenna J Phytomed       Date:  2015 Nov-Dec

7.  Validation of an HPLC Method for the Simultaneous Quantification of Metabolic Reaction Products Catalysed by CYP2C11 Enzymes in Rat Liver Microsomes: In Vitro Inhibitory Effect of Salicylic Acid on CYP2C11 Enzyme.

Authors:  Hassan Salhab; Declan P Naughton; James Barker
Journal:  Molecules       Date:  2019-11-25       Impact factor: 4.411

8.  Induction by Phenobarbital of Phase I and II Xenobiotic-Metabolizing Enzymes in Bovine Liver: An Overall Catalytic and Immunochemical Characterization.

Authors:  Michela Cantiello; Monica Carletti; Mery Giantin; Giulia Gardini; Francesca Capolongo; Paolo Cascio; Marianna Pauletto; Flavia Girolami; Mauro Dacasto; Carlo Nebbia
Journal:  Int J Mol Sci       Date:  2022-03-24       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.